<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0163185</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-22883</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Autoimmune diseases</subject><subj-group><subject>Psoriasis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Autoimmune diseases</subject><subj-group><subject>Psoriasis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Autoimmune diseases</subject><subj-group><subject>Psoriasis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genetics of disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genetics of disease</subject><subj-group><subject>Genetic predisposition</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Human genetics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genetic loci</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Genetics of the immune system</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Genetics of the immune system</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Genetics of the immune system</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Genetics of the immune system</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Genetics of the immune system</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Computational biology</subject><subj-group><subject>Genome analysis</subject><subj-group><subject>Genome-wide association studies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Genome analysis</subject><subj-group><subject>Genome-wide association studies</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Human genetics</subject><subj-group><subject>Genome-wide association studies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Evolutionary biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Population biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Evaluation of Psoriasis Genetic Risk Based on Five Susceptibility Markers in a Population from Northern Poland</article-title>
<alt-title alt-title-type="running-head">Psoriasis Genetic Risk Based on Five Susceptibility Markers</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Stawczyk-Macieja</surname>
<given-names>Marta</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Rębała</surname>
<given-names>Krzysztof</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Szczerkowska-Dobosz</surname>
<given-names>Aneta</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wysocka</surname>
<given-names>Joanna</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Cybulska</surname>
<given-names>Lidia</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kapińska</surname>
<given-names>Ewa</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Haraś</surname>
<given-names>Agnieszka</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Miniszewska</surname>
<given-names>Paulina</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Nowicki</surname>
<given-names>Roman</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, Gdańsk, Poland</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Forensic Medicine, Medical University of Gdańsk, Gdańsk, Poland</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Tang</surname>
<given-names>Jianming</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Alabama at Birmingham, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple">
<list-item><p><bold>Conceptualization:</bold> MS-M KR AS-D.</p></list-item>
<list-item><p><bold>Formal analysis:</bold> MS-M KR AS-D.</p></list-item>
<list-item><p><bold>Funding acquisition:</bold> MS-M RN.</p></list-item>
<list-item><p><bold>Investigation:</bold> MS-M.</p></list-item>
<list-item><p><bold>Methodology:</bold> MS-M KR JW LC EK AH PM.</p></list-item>
<list-item><p><bold>Supervision:</bold> AS-D RN.</p></list-item>
<list-item><p><bold>Validation:</bold> MS-M KR JW LC EK AH PM.</p></list-item>
<list-item><p><bold>Visualization:</bold> MS-M KR.</p></list-item>
<list-item><p><bold>Writing – original draft:</bold> MS-M KR AS-D.</p></list-item>
<list-item><p><bold>Writing – review &amp; editing:</bold> MS-M KR AS-D.</p></list-item></list></p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">m.macieja@gumed.edu.pl</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>9</issue>
<elocation-id>e0163185</elocation-id>
<history>
<date date-type="received">
<day>7</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>9</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Stawczyk-Macieja et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0163185"/>
<abstract>
<p>Psoriasis genetic background depends on polygenic and multifactorial mode of inheritance. As in other complex disorders, the estimation of the disease risk based on individual genetic variants is impossible. For this reason, recent investigations have been focused on combinations of known psoriasis susceptibility markers in order to improve the disease risk evaluation. Our aim was to compare psoriasis genetic risk score (GRS) for five susceptibility loci involved in the immunological response (<italic>HLA-C</italic>, <italic>ERAP1</italic>, <italic>ZAP70</italic>) and in the skin barrier function (<italic>LCE3</italic>, <italic>CSTA</italic>) between patients with chronic plaque psoriasis (n = 148) and the control group (n = 146). A significantly higher number of predisposing alleles was observed in patients with psoriasis in comparison to healthy individuals (6.1 vs. 5.2, respectively; P = 8.8×10<sup>−7</sup>). The statistical significance was even more profound when GRS weighted by logarithm odds ratios was evaluated (P = 9.9×10<sup>−14</sup>). Our results demonstrate the developed panel of five susceptibility loci to be more efficient in predicting psoriasis risk in the Polish population and to possess higher sensitivity and specificity for the disease than any of the markers analyzed separately, including the most informative <italic>HLA-C*06</italic> allele.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>Medical University of Gdańsk</institution>
</funding-source>
<award-id>MN 01-0041/08</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Stawczyk-Macieja</surname>
<given-names>Marta</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by a research grant from the Medical University of Gdańsk (MN 01-0041/08 and ST 02-0066/07).</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="4"/>
<page-count count="10"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Psoriasis is a chronic, inflammatory skin disease. It affects approximately 2–4% of Caucasian population, with higher prevalence in northern Europe [<xref ref-type="bibr" rid="pone.0163185.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0163185.ref003">3</xref>].</p>
<p>The role of genetic background in the pathogenesis of psoriasis is undoubted. Up to date, it has been classified as a complex disease with multifactorial mode of inheritance. The interactions between particular genes as well as genetic and environmental factors play an important role in the induction of psoriatic process.</p>
<p>According to the results of various linkage analyses performed on large family cohorts, <italic>psoriasis susceptibility 1</italic> (PSORS1) <italic>locus</italic> on chromosome 6 was proved to be significantly associated with psoriasis [<xref ref-type="bibr" rid="pone.0163185.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0163185.ref006">6</xref>]. Amongst 10 genes identified in the <italic>locus</italic>, <italic>HLA-C*06</italic> is considered to be the main psoriasis susceptibility marker [<xref ref-type="bibr" rid="pone.0163185.ref007">7</xref>–<xref ref-type="bibr" rid="pone.0163185.ref013">13</xref>]. Independent large-scale molecular studies confirmed a strong association of this allele with early-onset type of the disease in Caucasians [<xref ref-type="bibr" rid="pone.0163185.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0163185.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0163185.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0163185.ref013">13</xref>]. Nevertheless, <italic>HLA-C*06</italic> is estimated to be responsible for less than 50% of genetic predisposition to psoriasis [<xref ref-type="bibr" rid="pone.0163185.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0163185.ref006">6</xref>]. This fact suggests presence of non-MHC susceptibility polymorphisms, that may explain the complex nature of the disease.</p>
<p>Recent genome-wide association studies (GWAS) have led to identification of more than forty novel genetic risk factors associated with psoriasis. They include different polymorphisms of genes involved in the skin barrier function (<italic>LCE3B</italic>, <italic>LCE3C</italic>, <italic>CSTA</italic>), interleukin 12/interleukin 23 and NF-kappaB dependent signaling pathways (<italic>IL12B</italic>, <italic>IL23A</italic>, <italic>IL23R</italic>, <italic>TRAF3IP2</italic>, <italic>TYK2</italic>, <italic>TNFAIP3</italic>, <italic>TNIP1</italic>, <italic>NFKBIA</italic>, <italic>REL</italic>, <italic>IFIH1</italic>, <italic>IL28RA</italic>) as well as immunological response mediated by CD8+ lymphocytes (<italic>ERAP1</italic>, <italic>ZAP70</italic>) [<xref ref-type="bibr" rid="pone.0163185.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0163185.ref015">15</xref>]. Although proteins encoded by these genetic markers show biological epistasis, the majority of known polymorphisms associate with the risk of psoriasis independently. Compared to <italic>HLA-C*06</italic> alone, this effect provides only scant explanation of complexity in genetics of psoriasis.</p>
<p>In case of polygenic disorders, single genetic markers have small impact on phenotype and their presence do not allow to establish a definitive diagnosis. In order to improve disease risk prediction, certain combinations of such markers have been recently proposed [<xref ref-type="bibr" rid="pone.0163185.ref016">16</xref>–<xref ref-type="bibr" rid="pone.0163185.ref020">20</xref>].</p>
<p>In this study, we compared psoriasis genetic risk score (GRS) between patients with psoriasis and healthy controls by analysis of five known susceptibility markers: <italic>HLA-C*06</italic>, <italic>LCE3C_LCE3B-del</italic> and three single nucleotide polymorphisms (SNPs): rs26653 located within the <italic>ERAP1</italic> gene, rs17695937 linked to the <italic>ZAP70</italic> gene and rs17589 located within the <italic>CSTA</italic> gene. This is the first report on GRS estimation for a panel of psoriasis susceptibility loci in a population of patients with psoriasis from Eastern Europe.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec003">
<title>Selection of genetic risk markers</title>
<p>In our study, we focused on psoriasis susceptibility genes involved in the immunological response (<italic>HLA-C</italic>, <italic>ERAP1</italic>, <italic>ZAP70</italic>) and in the skin barrier function (<italic>LCE3</italic>, <italic>CSTA</italic>). For two genes, alleles with well documented genetic correlation with psoriasis: <italic>HLA-C*06</italic> and <italic>LCE3C_LCE3B-del</italic>, were chosen. The selection of SNPs from other psoriasis susceptibility loci (<italic>CSTA</italic>, <italic>ERAP1</italic> and <italic>ZAP70</italic>) was based on results of previous GWAS and large cohort studies. The markers included into the study demonstrated the strongest correlation with the risk of psoriasis in European populations and comprised c.162 T&gt;C within the <italic>CSTA</italic> gene (as studied by Vasilopoulos <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0163185.ref021">21</xref>] and identified in our study as rs17589), rs26653 within the <italic>ERAP1</italic> gene and rs17695937 linked to the <italic>ZAP70</italic> gene (<xref ref-type="table" rid="pone.0163185.t001">Table 1</xref>).</p>
<table-wrap id="pone.0163185.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0163185.t001</object-id>
<label>Table 1</label> <caption><title>The review of SNPs of <italic>CSTA</italic>, <italic>ERAP1</italic> and <italic>ZAP70</italic> genes, which were tested for correlation with the risk of psoriasis.</title></caption>
<alternatives>
<graphic id="pone.0163185.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0163185.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Gene</th>
<th align="left">SNP</th>
<th align="left">Reference</th>
<th align="left">OR (95% CI)</th>
<th align="left">P value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><italic>CSTA</italic></td>
<td align="left">CSTA SNP 1</td>
<td align="left">Samuelsson et al. [<xref ref-type="bibr" rid="pone.0163185.ref022">22</xref>]</td>
<td align="left">N/A</td>
<td align="left">1.00</td>
</tr>
<tr>
<td align="left"/>
<td align="left">CSTA SNP 3</td>
<td align="left"/>
<td align="left">N/A</td>
<td align="left">1.00</td>
</tr>
<tr>
<td align="left"/>
<td align="justify">g.-190 T&gt;C</td>
<td align="left">Vasilopoulos et al. [<xref ref-type="bibr" rid="pone.0163185.ref021">21</xref>]</td>
<td align="left">0.768 (0.45, 1.31)</td>
<td align="left">0.298</td>
</tr>
<tr>
<td align="left"/>
<td align="justify">c.162 T&gt;C<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left"/>
<td align="left">3.45 (2.28, 5.22)</td>
<td align="left">&lt;0.001</td>
</tr>
<tr>
<td align="left"/>
<td align="left">c.344 C&gt;T</td>
<td align="left"/>
<td align="left">1.505 (0.97, 2.34)</td>
<td align="left">&lt;0.054</td>
</tr>
<tr>
<td align="left"><italic>ERAP1</italic></td>
<td align="left">rs26653<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">Lysell et al. [<xref ref-type="bibr" rid="pone.0163185.ref023">23</xref>]</td>
<td align="left">1.31 (1.16–1.48)</td>
<td align="left">0.00006</td>
</tr>
<tr>
<td align="left"/>
<td align="left">rs30187</td>
<td align="left"/>
<td align="left">1.16 (1.03–1.30)</td>
<td align="left">0.02</td>
</tr>
<tr>
<td align="left"/>
<td align="left">rs27524</td>
<td align="left"/>
<td align="left">1.10 (0.98–1.23)</td>
<td align="left">0.11</td>
</tr>
<tr>
<td align="left"/>
<td align="left">rs27044</td>
<td align="left">Tang et al. [<xref ref-type="bibr" rid="pone.0163185.ref024">24</xref>]</td>
<td align="left">0.86 (0.83–0.89)</td>
<td align="left">2.16×10<sup>−14</sup></td>
</tr>
<tr>
<td align="left"/>
<td align="left">rs26653<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left"/>
<td align="left">0.87 (0.84–0.91)</td>
<td align="left">5.27×10<sup>−12</sup></td>
</tr>
<tr>
<td align="left"/>
<td align="left">rs27524</td>
<td align="left">Yang et al. [<xref ref-type="bibr" rid="pone.0163185.ref025">25</xref>]</td>
<td align="left">1.27 (1.10–1.46)</td>
<td align="left">1.17×10<sup>−3</sup></td>
</tr>
<tr>
<td align="left"/>
<td align="left">rs151823</td>
<td align="left">Sun et al. [<xref ref-type="bibr" rid="pone.0163185.ref026">26</xref>]</td>
<td align="left">0.89 (0.85–0.92)</td>
<td align="left">9.32×10<sup>−9</sup></td>
</tr>
<tr>
<td align="left"/>
<td align="left">rs27524</td>
<td align="left">Oostveen et al. [<xref ref-type="bibr" rid="pone.0163185.ref027">27</xref>]</td>
<td align="left">1.55 (1.18 to 2.03)</td>
<td align="left">0.002</td>
</tr>
<tr>
<td align="left"/>
<td align="left">rs27524</td>
<td align="left">Strange et al. [<xref ref-type="bibr" rid="pone.0163185.ref028">28</xref>]</td>
<td align="left">1.27 (1.18–1.38)</td>
<td align="left">4.24×10<sup>−11</sup></td>
</tr>
<tr>
<td align="left"><italic>ZAP70</italic></td>
<td align="left">rs17695937<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">Strange et al. [<xref ref-type="bibr" rid="pone.0163185.ref028">28</xref>]</td>
<td align="left">N/A</td>
<td align="left">2.37×10<sup>−7</sup></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>*SNPs selected for our study</p></fn>
<fn id="t001fn002"><p>SNP: single nucleotide polymorphism; N/A: not available</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec004">
<title>Subjects</title>
<p>A total of 294 individuals from northern Poland were enrolled in the case-control study, including 148 patients with psoriasis (79 males and 69 females) and 146 unrelated healthy controls (83 males and 63 females; <xref ref-type="table" rid="pone.0163185.t002">Table 2</xref>). The mean age of the case group was 43.3 years (range: 18–83). The mean age of the controls was 42.0 years (range: 19–84). No statistically significant differences in the gender distribution (Fisher exact test: P = 0.56) and in the age of the enrolled individuals (U Mann-Whitney test: P = 0.37) were revealed between the two groups. The patients were recruited at the Department of Dermatology, Venereology and Allergology at the University Clinical Centre in Gdańsk. They were qualified into the study based on the presence of skin lesions characteristic for plaque psoriasis assessed during dermatological examination. Guttate psoriasis, pustular psoriasis or psoriatic erythroderma were clinical types excluded from the study. There were neither personal nor familial history of psoriasis and/or psoriatic arthritis in the control group. All participants provided written informed consent and the study was approved by ethical committee of the Medical University of Gdańsk (NKBBN/181/2012).</p>
<table-wrap id="pone.0163185.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0163185.t002</object-id>
<label>Table 2</label> <caption><title>Cohort characteristics.</title></caption>
<alternatives>
<graphic id="pone.0163185.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0163185.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<tbody>
<tr>
<td align="center" rowspan="3"><bold>Patients with psoriasis</bold></td>
<td align="center"/>
<td align="center"><bold>Men</bold></td>
<td align="center"><bold>Women</bold></td>
<td align="center"><bold>Total</bold></td>
</tr>
<tr>
<td align="center"><bold>n</bold></td>
<td align="center">79</td>
<td align="center">69</td>
<td align="center">148</td>
</tr>
<tr>
<td align="center"><bold>Mean age (years)</bold></td>
<td align="center">41.50</td>
<td align="center">42.70</td>
<td align="center">43.30</td>
</tr>
<tr>
<td align="center" rowspan="3"><bold>Control group</bold></td>
<td align="center"/>
<td align="center"><bold>Men</bold></td>
<td align="center"><bold>Women</bold></td>
<td align="center"><bold>Total</bold></td>
</tr>
<tr>
<td align="center"><bold>n</bold></td>
<td align="center">83</td>
<td align="center">63</td>
<td align="center">146</td>
</tr>
<tr>
<td align="center"><bold>Mean age (years)</bold></td>
<td align="center">43.30</td>
<td align="center">43.30</td>
<td align="center">42.00</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec005">
<title>Genotype analysis</title>
<p>DNA samples were extracted from peripheral blood samples, using a modified method by Lahiri and Nurnberger [<xref ref-type="bibr" rid="pone.0163185.ref029">29</xref>]. <italic>HLA-C*06</italic> genotypes were determined by the optimized three-step procedure. Polymerase chain reaction (PCR) with sequence-specific primers (PCR-SSP) was used for specific detection of <italic>HLA-C*06</italic>. PCR with analysis of restriction fragment length polymorphism was used to distinguish between <italic>HLA-C*06</italic> homozygous and heterozygous subjects. Homozygous genotypes were additionally analyzed for nonspecific digestion by PCR-SSP [<xref ref-type="bibr" rid="pone.0163185.ref030">30</xref>,<xref ref-type="bibr" rid="pone.0163185.ref031">31</xref>]. Identification of <italic>LCE3C_LCE3B-del</italic> alleles was performed by PCR with evaluation of amplified fragment length polymorphism (PCR-AFLP), described previously in the study by de Cid <italic>et al</italic>. [<xref ref-type="bibr" rid="pone.0163185.ref032">32</xref>]. Three different primers were used for the reaction (<xref ref-type="supplementary-material" rid="pone.0163185.s001">S1 Table</xref>). A specific product of 240 base pairs (bp) in length without the deletion was amplified with LCE3C_F and LCE3C_R primers. <italic>LCE3C_LCE3B-del</italic> allele of 199 bp in length was detected by LCE3C_F and LCE3CR2D primers. After optimization of temperature of hybridization of specific primers used to detect SNPs of <italic>ERAP1</italic>, <italic>CSTA</italic> and <italic>ZAP70</italic> genes, discrimination of rs26653, rs17589 and rs17695937 alleles was performed by PCR-SSP method (<xref ref-type="supplementary-material" rid="pone.0163185.s001">S1 Table</xref>). In order to ensure quality control in all cases, a negative non-template control as well as an internal positive control of amplification were used to eliminate genotype mistakes. The PCR products were analyzed by polyacrylamide gel electrophoresis and stained with silver.</p>
</sec>
<sec id="sec006">
<title>Genetic risk score calculation</title>
<p>As far as some DNA samples did not show products of amplification of one or more markers, the GRS evaluation based on five susceptibility loci was performed on the population of 126 patients with psoriasis and 100 healthy controls with complete genotypes for five genetic polymorphisms. MedCalc 16 (MedCalc Software bvba) was used for multivariate logistic regression analysis adjusted for gender and age and for odds ratio (OR) estimation. Two methods described in the study by Chen <italic>et al</italic>. were used to obtain GRS scores [<xref ref-type="bibr" rid="pone.0163185.ref019">19</xref>]. The count GRS (cGRS) calculation was based on a simple counting of alleles predisposing to psoriasis, whereas weighted GRS (wGRS) was computed as the number of risk alleles multiplied by logarithm odds ratio (Log(OR)) for each of five alleles in the panel. Descriptive statistics of cGRS and wGRS values were performed with the use of STATISTICA 12 package (StatSoft Inc.). Since both parameters did not display normal distribution, the nonparametric U Mann-Whitney test was used in order to compare cGRS and wGRS values in the case-control cohort. Receiver operating characteristic (ROC) curves for the five individual susceptibility markers as well as for cGRS and wGRS values were obtained in STATISTICA 12. Areas under ROC curves (AUCs) for different predictors were compared by a method described by DeLong <italic>et al</italic>., as applied in MedCalc 16 software [<xref ref-type="bibr" rid="pone.0163185.ref033">33</xref>]. All statistical tests were two-sided and a standard significance level of 0.05 was used.</p>
</sec>
</sec>
<sec id="sec007" sec-type="results">
<title>Results</title>
<sec id="sec008">
<title>The association of risk alleles with psoriasis</title>
<p>All allelic frequencies of patients and control subjects were in Hardy-Weinberg equilibrium (P&gt;0.05). Out of the five tested psoriasis susceptibility markers, only HLA-C*06 and rs26653 G alleles showed statistically significant association with the disease (<xref ref-type="table" rid="pone.0163185.t003">Table 3</xref>). The odds ratios for each of the predisposing alleles and corresponding confidence intervals are shown in <xref ref-type="table" rid="pone.0163185.t003">Table 3</xref>.</p>
<table-wrap id="pone.0163185.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0163185.t003</object-id>
<label>Table 3</label> <caption><title>The odds ratios for each of the analyzed psoriasis genetic markers in the case-control samples from northern Poland.</title></caption>
<alternatives>
<graphic id="pone.0163185.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0163185.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify">Gene</th>
<th align="justify">Predisposing allele</th>
<th align="justify">OR</th>
<th align="justify">95% CI</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><italic>HLA-C</italic></td>
<td align="left"><italic>HLA-C*06</italic></td>
<td align="left">7.42</td>
<td align="left">3.94–13.98</td>
</tr>
<tr>
<td align="left"><italic>ERAP1</italic></td>
<td align="left">rs26653 G</td>
<td align="left">2.26</td>
<td align="left">1.44–3.54</td>
</tr>
<tr>
<td align="left"><italic>LCE3</italic></td>
<td align="left"><italic>LCE3C_LCE3B-del</italic></td>
<td align="left">1.19</td>
<td align="left">0.75–1.89</td>
</tr>
<tr>
<td align="left"><italic>CSTA</italic></td>
<td align="left">rs17589 T</td>
<td align="left">1.12</td>
<td align="left">0.54–2.32</td>
</tr>
<tr>
<td align="left"><italic>ZAP70</italic></td>
<td align="left">rs17695937 A</td>
<td align="left">1.05</td>
<td align="left">0.59–1.87</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>OR: odds ratio; CI: confidence interval</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec009">
<title>Genetic risk score calculation</title>
<p>The calculation of GRS was based on five risk alleles contributing to the risk of psoriasis regardless of statistical significance. Mean cGRS and wGRS in the population of patients with psoriasis were 6.1 and 3.2, respectively. The control group showed mean cGRS of 5.2 and mean wGRS of 1.9.The results revealed a significant difference between patients with psoriasis and healthy controls. Psoriatic subjects demonstrated significantly higher cGRS and wGRS values in comparison with healthy individuals (<xref ref-type="table" rid="pone.0163185.t004">Table 4</xref>).</p>
<table-wrap id="pone.0163185.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0163185.t004</object-id>
<label>Table 4</label> <caption><title>Comparison of cGRS and wGRS values for the tested panel of five susceptibility markers between patients with psoriasis and healthy controls.</title></caption>
<alternatives>
<graphic id="pone.0163185.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0163185.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">GRS</th>
<th align="left">Group</th>
<th align="left">Mean</th>
<th align="left">SD</th>
<th align="left">Median</th>
<th align="left">IQR</th>
<th align="left">P value<xref ref-type="table-fn" rid="t004fn001">*</xref></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">cGRS</td>
<td align="left">Psoriasis</td>
<td align="left">6.06</td>
<td align="left">1.19</td>
<td align="left">6.00</td>
<td align="left">2.00</td>
<td align="left">8.76×10<sup>−7</sup></td>
</tr>
<tr>
<td align="left"/>
<td align="left">Control</td>
<td align="left">5.21</td>
<td align="left">1.25</td>
<td align="left">5.00</td>
<td align="left">2.00</td>
<td align="left"/>
</tr>
<tr>
<td align="left">wGRS</td>
<td align="left">Psoriasis</td>
<td align="left">3.17</td>
<td align="left">1.11</td>
<td align="left">3.35</td>
<td align="left">1.94</td>
<td align="left">9.89×10<sup>−14</sup></td>
</tr>
<tr>
<td align="left"/>
<td align="left">Control</td>
<td align="left">1.93</td>
<td align="left">1.07</td>
<td align="left">1.99</td>
<td align="left">1.05</td>
<td align="left"/>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>*U Mann-Whitney test</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The ROC curves for prediction of psoriasis with the use of the tested markers are shown in <xref ref-type="fig" rid="pone.0163185.g001">Fig 1</xref>. The area under ROC curve (AUC) for wGRS was statistically larger than AUC for cGRS (0.789 vs. 0.685; P = 0.0002). It was also statistically larger than AUC for any of the five susceptibility markers analyzed separately, including the most informative <italic>HLA-C*06</italic> allele (AUC = 0.722; P &lt; 0.0001). No statistically significant difference was observed between AUCs for cGRS and <italic>HLA-C*06</italic> (P = 0.3437).</p>
<fig id="pone.0163185.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0163185.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Comparison of ROC curves for prediction of psoriasis with the use of five psoriasis susceptibility markers analyzed separately and for cGRS and wGRS values obtained for these markers.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0163185.g001" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec010" sec-type="conclusions">
<title>Discussion</title>
<p>Psoriasis is a common, inflammatory and hyperproliferative disease of skin and joints, with proven genetic basis. Numerous genome-wide association studies have recently led to identification of novel genetic risk markers associated with the disease [<xref ref-type="bibr" rid="pone.0163185.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0163185.ref015">15</xref>]. Although their biological role may explain particular mechanisms arranged in the pathogenesis of psoriasis, the real effect of these variants on phenotype is modest. Due to complex nature of psoriasis, the disease risk prediction based on individual known susceptibility genes with low penetrance is limited. It has been shown that combining multiple risk loci with modest effects, identified previously in GWAS, into a global genetic risk score might improve identification of persons who are at increased risk for common complex diseases. This observation led to evaluation of genetic risk score based on the combination of known risk alleles in prediction of psoriasis [<xref ref-type="bibr" rid="pone.0163185.ref019">19</xref>].</p>
<p>Our aim was to determine the psoriasis GRS for five genetic risk variants whose contribution to the development of psoriasis was confirmed previously in linkage analysis and GWAS in large cohorts [<xref ref-type="bibr" rid="pone.0163185.ref007">7</xref>–<xref ref-type="bibr" rid="pone.0163185.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0163185.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0163185.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0163185.ref028">28</xref>,<xref ref-type="bibr" rid="pone.0163185.ref034">34</xref>–<xref ref-type="bibr" rid="pone.0163185.ref036">36</xref>].</p>
<p>The association of <italic>LCE3C_LCE3B-del</italic> with the risk of psoriasis has been proved in ethnically diverse populations [<xref ref-type="bibr" rid="pone.0163185.ref034">34</xref>–<xref ref-type="bibr" rid="pone.0163185.ref036">36</xref>]. Numerous SNPs within the <italic>ERAP1</italic> gene have been analyzed in the context of predisposition to psoriasis, but the strongest association with the disease in a European population has been proved for rs26653 (P = 0.00006) [<xref ref-type="bibr" rid="pone.0163185.ref023">23</xref>] and was confirmed by Tang <italic>et al</italic>. in Chinese patients (P = 5.27×10<sup>−12</sup>) [<xref ref-type="bibr" rid="pone.0163185.ref024">24</xref>]. Up to date, different polymorphisms within the <italic>ZAP70</italic> gene have been suggested to predispose to psoriasis [<xref ref-type="bibr" rid="pone.0163185.ref028">28</xref>,<xref ref-type="bibr" rid="pone.0163185.ref037">37</xref>] and rs17695937 has been shown by Strange <italic>et al</italic>. to associate with the disease (P = 2.37×10<sup>−7</sup>) [<xref ref-type="bibr" rid="pone.0163185.ref028">28</xref>]. In 2008, Vasilopoulos <italic>et al</italic>. investigated three genetic markers in the <italic>CSTA</italic> gene, but the strongest effect on psoriasis risk was found for rs17589 (P&lt;0.001) [<xref ref-type="bibr" rid="pone.0163185.ref021">21</xref>].</p>
<p>The odds ratios revealed that <italic>HLA-C*06</italic>, rs26653 G, <italic>LCE3C_LCE3B-del</italic>, rs17589 T and rs17695937 A alleles predispose to psoriasis, but the results were statistically significant only in case of <italic>HLA-C*06</italic> and rs26653 G. The lack of significant association of <italic>LCE3C_LCE3B-del</italic>, rs17589 and rs17695937 alleles with psoriasis may result from the fact that the studied population was relatively small when compared to other investigations. Therefore, further analysis with a larger sample size is necessary to confirm these associations in Polish patients with psoriasis.</p>
<p>Independent studies revealed that weighted GRS is a better risk predictor in complex disorders than count GRS, as far as it accommodates differences in allelic influence on genetic predisposition to the disease [<xref ref-type="bibr" rid="pone.0163185.ref019">19</xref>,<xref ref-type="bibr" rid="pone.0163185.ref038">38</xref>]. In the present study, both mean wGRS and cGRS values were significantly higher in patients with psoriasis than in controls. The comparison of cGRS between the studied groups has shown that patients with psoriasis carry significantly more risk alleles than healthy individuals (on the average 6.1 alleles in psoriasis versus 5.2 alleles in the control group; P = 0.0000009). As mentioned above, cGRS calculation does not take into account the differences between particular alleles in predisposition to psoriasis, so our cGRS values are likely to be overestimated due to inclusion of predisposing alleles without statistical significance. Therefore, we additionally assessed wGRS values, and since they are weighted by logarithm odds ratios, the impact of alleles with OR values slightly exceeding 1 on the final wGRS values was negligible but still worthy of consideration as far as they may show statistical significance in larger cohorts as demonstrated by other authors. We found higher wGRS values in subjects with psoriasis than in healthy individuals (on the average 3.2 and 1.9 in patients with psoriasis and in the control group, respectively; P = 0.0000000000001). Thus, the observed difference was even more significant than in the cGRS evaluation. Moreover, also the comparison of ROC curves confirmed that wGRS assessed for the five markers is better for prediction of the risk of psoriasis than cGRS. The computed odds ratios revealed that within five genetic polymorphisms evaluated in this study, <italic>HLA-C*06</italic> demonstrated the strongest effect on the risk of psoriasis. These findings are consistent with other large-scale observations and confirm <italic>HLA-C*06</italic> to be a major psoriasis susceptibility genetic marker [<xref ref-type="bibr" rid="pone.0163185.ref007">7</xref>–<xref ref-type="bibr" rid="pone.0163185.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0163185.ref019">19</xref>]. Anyway, our results show the developed panel of five susceptibility loci to be more efficient in predicting psoriasis risk and to possess higher sensitivity and specificity for the disease than any of the markers analyzed separately, including the most informative <italic>HLA-C*06</italic> allele.</p>
<p>In 2011, Chen <italic>et al</italic>. worked out a panel of ten known psoriasis susceptibility genes, including <italic>HLA-C</italic> [<xref ref-type="bibr" rid="pone.0163185.ref019">19</xref>]. The study assumed evaluation of GRS and relationship between selected alleles and psoriatic subphenotypes. The results of the study showed that wGRS which included ten known risk alleles presented stronger association with psoriasis than any single SNP individually. Subjects in the highest wGRS quartile demonstrated a greater than 10-fold increased predisposition to the disease in comparison to individuals in the lowest quartile. Moreover, out of ten analyzed polymorphisms, the strongest signal was found at the <italic>HLA-C</italic> locus, which was in accordance with our results. The study also revealed that the prognostic value of nine genetic markers combined together was comparable to <italic>HLA-C*06</italic> alone. The combination of nine non-MHC genetic markers presented similar association with the risk of psoriasis to <italic>HLA-C</italic>. Nevertheless, the cumulative effect was stronger in context of wGRS estimation than in the individual approach. On the other hand, none of nine risk alleles mentioned above was shown to interact with <italic>HLA-C*06</italic>. Our preliminary data did not show any interaction between analyzed genetic variants as well. On the contrary, other studies showed that polymorphisms in <italic>LCE3C_LCE3B</italic>, <italic>ERAP1</italic> and <italic>ZAP70</italic> genes, selected for our investigation, interact with <italic>HLA-C*06</italic> [<xref ref-type="bibr" rid="pone.0163185.ref028">28</xref>,<xref ref-type="bibr" rid="pone.0163185.ref032">32</xref>,<xref ref-type="bibr" rid="pone.0163185.ref039">39</xref>–<xref ref-type="bibr" rid="pone.0163185.ref041">41</xref>]. Another study by Vasilopoulos <italic>et al</italic>. revealed a greater than 100-fold increase of psoriasis risk in patients carrying only three susceptibility markers: <italic>HLA-C</italic>, <italic>CSTA</italic> and D1S2346. In this case, investigated genetic markers also demonstrated epistatic interaction [<xref ref-type="bibr" rid="pone.0163185.ref020">20</xref>].</p>
<p>Genetic risk prediction based on panels comprising known risk alleles is a novel trend in context of complex disorders. The results of our study confirm that the combination of <italic>HLA-C*06</italic>, rs26653 G, <italic>LCE3C_LCE3B-del</italic>, rs17589 T and rs17695937 G displays a very significant effect on the risk of psoriasis and may be used in practice for its prediction. Further investigations with larger sample sizes from various ethnic groups are likely to confirm association of the studied markers with psoriasis in populations from Eastern Europe as well as to verify usefulness of the proposed panel of markers for prediction of psoriasis risk in other populations.</p>
</sec>
<sec id="sec011">
<title>Supporting Information</title>
<supplementary-material id="pone.0163185.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0163185.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Sequences of primers used for genotyping of <italic>ERAP1</italic>, <italic>ZAP70</italic> and <italic>CSTA</italic> variants.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0163185.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kurd</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Gelfand</surname> <given-names>JM</given-names></name>. <article-title>The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004</article-title>. <source>J Am Acad Dermatol</source>. <year>2009</year>; <volume>60</volume>: <fpage>218</fpage>–<lpage>224</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jaad.2008.09.022" xlink:type="simple">10.1016/j.jaad.2008.09.022</ext-link></comment> <object-id pub-id-type="pmid">19022533</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gelfand</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Weinstein</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Porter</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Neimann</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Berlin</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Margolis</surname> <given-names>DJ</given-names></name>. <article-title>Prevalence and treatment of psoriasis in the United Kingdom—a population-based study</article-title>. <source>Arch Dermatol</source>. <year>2005</year>; <volume>141</volume>: <fpage>1537</fpage>–<lpage>1541</lpage>. <object-id pub-id-type="pmid">16365254</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Christophers</surname> <given-names>E</given-names></name>. <article-title>Psoriais-epidemiology and clinical spectrum</article-title>. <source>Clin Exp Dermatol</source>. <year>2001</year>; <volume>26</volume>: <fpage>314</fpage>–<lpage>320</lpage>. <object-id pub-id-type="pmid">11422182</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Allen</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Veal</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Faassen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Powis</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Vaughan</surname> <given-names>RW</given-names></name>, <name name-style="western"><surname>Trembath</surname> <given-names>RC</given-names></name>, <etal>et al</etal>. <article-title>A non-HLA gene within the MHC in psoriasis</article-title>. <source>Lancet</source>. <year>1999</year>; <volume>353</volume>: <fpage>1589</fpage>–<lpage>1590</lpage>. <object-id pub-id-type="pmid">10334264</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Asumalahti</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Veal</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Laitinen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Suomela</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Allen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Elomaa</surname> <given-names>O</given-names></name>, <etal>et al</etal>. <article-title>Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus</article-title>. <source>Hum Mol Genet</source>. <year>2002</year>; <volume>11</volume>: <fpage>589</fpage>–<lpage>597</lpage>. <object-id pub-id-type="pmid">11875053</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trembath</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Clough</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Rosbotham</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Camp</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Frodsham</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Identification of a major suspectibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis</article-title>. <source>Hum Mol Genet</source>. <year>1997</year>; <volume>6</volume>: <fpage>813</fpage>–<lpage>820</lpage>. <object-id pub-id-type="pmid">9158158</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nair</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Stuart</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Nistor</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hiremagalore</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Chia</surname> <given-names>NV</given-names></name>, <name name-style="western"><surname>Jenisch</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene</article-title>. <source>Am J Hum Genet</source>. <year>2006</year>; <volume>78</volume>: <fpage>827</fpage>–<lpage>851</lpage>. <object-id pub-id-type="pmid">16642438</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ikaheimo</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Silvennoinen-Kassinen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Karvonen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tiilikainen</surname> <given-names>A</given-names></name>. <article-title>Alanine at position 73 of HLA–C is associated with psoriasis vulgaris in Finland</article-title>. <source>Br J Dermatol</source>. <year>1994</year>; <volume>131</volume>: <fpage>257</fpage>–<lpage>259</lpage>. <object-id pub-id-type="pmid">7917991</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Enerback</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Nilsson</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Enlund</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Inerot</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Samuelsson</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wahlstrom</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Stronger association with HLA–Cw6 than corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients</article-title>. <source>Arc Dermatol Res</source>. <year>2000</year>; <volume>292</volume>: <fpage>525</fpage>–<lpage>530</lpage>.</mixed-citation></ref>
<ref id="pone.0163185.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gudjonsson</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Karason</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Runarsdottir</surname> <given-names>EH</given-names></name>, <name name-style="western"><surname>Antonsdottir</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Hauksson</surname> <given-names>VB</given-names></name>, <name name-style="western"><surname>Jónsson</surname> <given-names>HH</given-names></name>, <etal>et al</etal>. <article-title>Distinct clinical differences between HLA–Cw*0602 positive and negative psoriasis patients—an analysis of 1019 HLA–C- and HLA–B-typed patients</article-title>. <source>J Invest Dermatol</source>. <year>2006</year>; <volume>126</volume>: <fpage>740</fpage>–<lpage>745</lpage>. <object-id pub-id-type="pmid">16439971</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>XD</given-names></name>. <article-title>Association between HLA-Cw*0602 polymorphism and psoriasis risk: a meta-analysis</article-title>. <source>Genet Mol Res</source>. <year>2011</year>; <volume>10</volume>: <fpage>3109</fpage>–<lpage>3120</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4238/2011.December.15.2" xlink:type="simple">10.4238/2011.December.15.2</ext-link></comment> <object-id pub-id-type="pmid">22194166</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gudjonsson</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Karason</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Antonsdottir</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Runarsdottir</surname> <given-names>EH</given-names></name>, <name name-style="western"><surname>Hauksson</surname> <given-names>VB</given-names></name>, <name name-style="western"><surname>Upmanyu</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Psoriasis patients who are homozygous for the HLA–Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes</article-title>. <source>Br J Dermatol</source>. <year>2003</year>; <volume>148</volume>: <fpage>233</fpage>–<lpage>235</lpage>. <object-id pub-id-type="pmid">12588373</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Szczerkowska-Dobosz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rębała</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Szczerkowska</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Witkowska-Toboła</surname> <given-names>A</given-names></name>. <article-title>Correlation of HLA–Cw*06 allele frequency with some clinical features of psoriasis vulgaris in the population of northern Poland</article-title>. <source>J Appl Genet</source>. <year>2004</year>; <volume>45</volume>: <fpage>473</fpage>–<lpage>476</lpage>. <object-id pub-id-type="pmid">15523160</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chandran</surname> <given-names>V</given-names></name>. <article-title>The genetics of psoriasis and psoriatic arthritis</article-title>. <source>Clin Rev Allergy Immunol</source>. <year>2013</year>; <volume>44</volume>: <fpage>149</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s12016-012-8303-5" xlink:type="simple">10.1007/s12016-012-8303-5</ext-link></comment> <object-id pub-id-type="pmid">22274791</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Elder</surname> <given-names>JT</given-names></name>. <article-title>Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis</article-title>. <source>Genes Immun</source>. <year>2009</year>; <volume>10</volume>: <fpage>201</fpage>–<lpage>209</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/gene.2009.11" xlink:type="simple">10.1038/gene.2009.11</ext-link></comment> <object-id pub-id-type="pmid">19262574</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meigs</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Shrader</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sullivan</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>McAteer</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Fox</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Dupuis</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Genotype score in addition to common risk factors for prediction of type 2 diabetes</article-title>. <source>N Engl J Med</source>. <year>2008</year>; <volume>359</volume>: <fpage>2208</fpage>–<lpage>2219</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa0804742" xlink:type="simple">10.1056/NEJMoa0804742</ext-link></comment> <object-id pub-id-type="pmid">19020323</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weedon</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>McCarthy</surname> <given-names>MI</given-names></name>, <name name-style="western"><surname>Hitman</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Groves</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Zeggini</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Combining information from common type 2 diabetes risk polymorphisms improves disease prediction</article-title>. <source>PLoS Med</source>. <year>2006</year>; <volume>3</volume>: <fpage>e374</fpage>. <object-id pub-id-type="pmid">17020404</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wray</surname> <given-names>NR</given-names></name>, <name name-style="western"><surname>Goddard</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Visscher</surname> <given-names>PM</given-names></name>. <article-title>Prediction of individual genetic risk to disease from genome-wide association studies</article-title>. <source>Genome Res</source>. <year>2007</year>; <volume>17</volume>: <fpage>1520</fpage>–<lpage>1528</lpage>. <object-id pub-id-type="pmid">17785532</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Poon</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Yeung</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Helms</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pons</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bowcock</surname> <given-names>AM</given-names></name>, <etal>et al</etal>. <article-title>A genetic risk score combining ten psoriasis risk loci improves disease prediction</article-title>. <source>PLoS One</source>. <year>2011</year>; <volume>6</volume>: <fpage>e19454</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0019454" xlink:type="simple">10.1371/journal.pone.0019454</ext-link></comment> <object-id pub-id-type="pmid">21559375</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasilopoulos</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sagoo</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Cork</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Walters</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tazi-Ahnini</surname> <given-names>R</given-names></name>. <article-title>HLA-C, CSTA and DS12346 susceptibility alleles confer over 100-fold increased risk of developing psoriasis: evidence of gene interaction</article-title>. <source>J Hum Genet</source>. <year>2011</year>; <volume>56</volume>: <fpage>423</fpage>–<lpage>427</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jhg.2011.33" xlink:type="simple">10.1038/jhg.2011.33</ext-link></comment> <object-id pub-id-type="pmid">21412248</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasilopoulos</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Walters</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Cork</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Duff</surname> <given-names>GW</given-names></name>, <name name-style="western"><surname>Sagoo</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Tazi-Ahnini</surname> <given-names>R</given-names></name>. <article-title>Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5</article-title>. <source>Eur J Hum Genet</source>. <year>2008</year>; <volume>16</volume>: <fpage>1002</fpage>–<lpage>1009</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ejhg.2008.40" xlink:type="simple">10.1038/ejhg.2008.40</ext-link></comment> <object-id pub-id-type="pmid">18364739</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Samuelsson</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Stiller</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Friberg</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Nilsson</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Inerot</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wahlström</surname> <given-names>J</given-names></name>. <article-title>Association analysis of cystatin A and zinc finger protein 148, two genes located at the psoriasis susceptibility locus PSORS5</article-title>. <source>J Invest Dermatol</source> <year>2004</year>; <volume>122</volume>: <fpage>1399</fpage>–<lpage>1400</lpage>. <object-id pub-id-type="pmid">15175029</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lysell</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Padyukov</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Kockum</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Nikamo</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Ståhle</surname> <given-names>M</given-names></name>. <article-title>Genetic association with ERAP1 in psoriasis is confined to disease onset after puberty and not dependent on HLA-C*06</article-title>. <source>J Invest Dermatol</source>. <year>2013</year>; <volume>133</volume>: <fpage>411</fpage>–<lpage>417</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jid.2012.280" xlink:type="simple">10.1038/jid.2012.280</ext-link></comment> <object-id pub-id-type="pmid">22931917</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Jin</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>X</given-names></name>, <etal>et al</etal>. <article-title>A large-scale screen for coding variants predisposing to psoriasis</article-title>. <source>Nat Genet</source>. <year>2014</year>; <volume>46</volume>: <fpage>45</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.2827" xlink:type="simple">10.1038/ng.2827</ext-link></comment> <object-id pub-id-type="pmid">24212883</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Qu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Investigation of 20 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris</article-title>. <source>Br J Dermatol</source>. <year>2013</year>; <volume>168</volume>: <fpage>1060</fpage>–<lpage>1065</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/bjd.12142" xlink:type="simple">10.1111/bjd.12142</ext-link></comment> <object-id pub-id-type="pmid">23252691</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname> <given-names>LD</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>ZX</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>AP</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>JH</given-names></name>, <etal>et al</etal>. <article-title>Association analyses identify six new psoriasis susceptibility loci in the Chinese population</article-title>. <source>Nat Genet</source>. <year>2010</year>; <volume>42</volume>: <fpage>1005</fpage>–<lpage>1009</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.690" xlink:type="simple">10.1038/ng.690</ext-link></comment> <object-id pub-id-type="pmid">20953187</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oostveen</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Bergboer</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>van de Kerkhof</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Zeeuwen</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>de Jong</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Schalkwijk</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Genotype-phenotype correlations in a prospective cohort study of paediatric plaque psoriasis: lack of correlation between HLA-C*06 and family history of psoriasis</article-title>. <source>Acta Derm Venereol</source>. <year>2014</year>; <volume>94</volume>: <fpage>667</fpage>–<lpage>671</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2340/00015555-1810" xlink:type="simple">10.2340/00015555-1810</ext-link></comment> <object-id pub-id-type="pmid">24791935</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Strange</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Capon</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Spencer</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Knight</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Weale</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Allen</surname> <given-names>MH</given-names></name>, <etal>et al</etal>. <article-title>A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1</article-title>. <source>Nat Genet</source>. <year>2010</year>; <volume>42</volume>: <fpage>985</fpage>–<lpage>990</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.694" xlink:type="simple">10.1038/ng.694</ext-link></comment> <object-id pub-id-type="pmid">20953190</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lahiri</surname> <given-names>DK</given-names></name>, <name name-style="western"><surname>Nurnberger</surname> <given-names>JI</given-names></name>. <article-title>A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies</article-title>. <source>Nucleic Acids Res</source>. <year>1991</year>; <volume>19</volume>: <fpage>5444</fpage>. <object-id pub-id-type="pmid">1681511</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref030"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Szczerkowska-Dobosz A. Analiza kliniczna łuszczycy z początkiem po trzydziestym roku życia oraz znaczenie zmodyfikowanej metody PCR do oznaczania allelu HLA-Cw*06: wskaźnika genetycznego zróżnicowania tej choroby. Habilitation Thesis, Medical University of Gdańsk. Ann. Acad. Med. Gedan., 2009, 39, supl. 1. Available: <ext-link ext-link-type="uri" xlink:href="http://pbc.gda.pl/Content/5785" xlink:type="simple">http://pbc.gda.pl/Content/5785</ext-link>.</mixed-citation></ref>
<ref id="pone.0163185.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rębała</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Szczerkowska-Dobosz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Niespodziana</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Wysocka</surname> <given-names>J</given-names></name>. <article-title>Simple and rapid screening for HLA-Cw*06 in Polish patients with psoriasis</article-title>. <source>Clin Exp Dermatol</source>. <year>2010</year>; <volume>35</volume>: <fpage>431</fpage>–<lpage>436</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2230.2009.03627.x" xlink:type="simple">10.1111/j.1365-2230.2009.03627.x</ext-link></comment> <object-id pub-id-type="pmid">19874367</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Cid</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Riveira-Munoz</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Zeeuwen</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Robarge</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Liao</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Dannhauser</surname> <given-names>EN</given-names></name>, <etal>et al</etal>. <article-title>Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis</article-title>. <source>Nat Genet</source>. <year>2009</year>; <volume>41</volume>: <fpage>211</fpage>–<lpage>215</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.313" xlink:type="simple">10.1038/ng.313</ext-link></comment> <object-id pub-id-type="pmid">19169253</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DeLong</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>DeLong</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Clarke-Pearson</surname> <given-names>DL</given-names></name>. <article-title>Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach</article-title>. <source>Biometrics</source>. <year>1988</year>; <volume>44</volume>: <fpage>837</fpage>–<lpage>845</lpage>. <object-id pub-id-type="pmid">3203132</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hüffmeier</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Bergboer</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Becker</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Armour</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Traupe</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Estivill</surname> <given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Replication of LCE3C-LCE3B CNV as a risk factor for psoriasis and analysis of interaction with other genetic risk factors</article-title>. <source>J Invest Dermatol</source>. <year>2010</year>; <volume>130</volume>: <fpage>979</fpage>–<lpage>984</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jid.2009.385" xlink:type="simple">10.1038/jid.2009.385</ext-link></comment> <object-id pub-id-type="pmid">20016497</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>Deletion of the late cornified envelope genes LCE3C and LCE3B is associated with psoriasis in a Chinese population</article-title>. <source>J Invest Dermatol</source>. <year>2011</year>; <volume>131</volume>: <fpage>1639</fpage>–<lpage>1643</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jid.2011.86" xlink:type="simple">10.1038/jid.2011.86</ext-link></comment> <object-id pub-id-type="pmid">21509048</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Riveira-Munoz</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Escaramís</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Stuart</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Hüffmeier</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6</article-title>. <source>J Invest Dermatol</source>. <year>2011</year>; <volume>131</volume>: <fpage>1105</fpage>–<lpage>1109</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jid.2010.350" xlink:type="simple">10.1038/jid.2010.350</ext-link></comment> <object-id pub-id-type="pmid">21107349</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Jeong</surname> <given-names>HO</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>BC</given-names></name>, <name name-style="western"><surname>Ha</surname> <given-names>YM</given-names></name>, <name name-style="western"><surname>Young Chung</surname> <given-names>H</given-names></name>. <article-title>Computational approach to identify enzymes that are potential therapeutic candidates for psoriasis</article-title>. <source>Enzyme Res</source>. <year>2011</year>: <fpage>826784</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4061/2011/826784" xlink:type="simple">10.4061/2011/826784</ext-link></comment> <object-id pub-id-type="pmid">21822480</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Piccolo</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Abo</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Allen-Brady</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Camp</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Knight</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>JL</given-names></name>, <etal>et al</etal>. <article-title>Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study</article-title>. <source>BMC Proc</source>. <year>2009</year>; <volume>3</volume>: <fpage>S46</fpage>. <object-id pub-id-type="pmid">20018038</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Capon</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Semprini</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Dallapicola</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Novelli</surname> <given-names>G</given-names></name>. <article-title>Evidence for interaction between psoriasis-suseptibility loci on chromosomes 6p21 and 6q21</article-title>. <source>Am J Hum Genet</source>. <year>1999</year>; <volume>65</volume>: <fpage>1798</fpage>–<lpage>1800</lpage>. <object-id pub-id-type="pmid">10577939</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coto</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Santos-Juanes</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Coto-Segura</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Díaz</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Soto</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Queiro</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Mutation analysis of the LCE3B/LCE3C genes in psoriasis</article-title>. <source>BMC Med Genet</source>. <year>2010</year>; <volume>11</volume>: <fpage>45</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2350-11-45" xlink:type="simple">10.1186/1471-2350-11-45</ext-link></comment> <object-id pub-id-type="pmid">20331852</object-id></mixed-citation></ref>
<ref id="pone.0163185.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hüffmeier</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Estivill</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Riveira-Munoz</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Traupe</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wendler</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lohmann</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to susceptibility to psoriatic arthritis in German patients</article-title>. <source>Ann Rheum Dis</source>. <year>2010</year>; <volume>69</volume>: <fpage>876</fpage>–<lpage>878</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/ard.2009.108951" xlink:type="simple">10.1136/ard.2009.108951</ext-link></comment> <object-id pub-id-type="pmid">19439430</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>